Trial · NCT01780935
Outcomes13
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Average Best-corrected Visual Acuity (BCVA) (Letters) Change up to Month 12 | up to Month 12 | Full Analysis Set (FAS) includes all randomized patients | Letters correctly read | MEAN |
| SECONDARY | Change From Baseline in Visual Acuity (Letters) of the Study Eye up to Month 12 | up to Month 12 | Full Analysis Set (FAS) includes all randomized patients | letters correctly read | MEAN |
| SECONDARY | Gain of Equal or More Than 1, 5, 10, or 15 Letters in Visual Acuity of the Study Eye From Baseline, at Month 12 and 24 | Baseline to Month 12 and 24 | Early termination of the study, therefore the 12-month cutoff date was not reached and the related analysis was not performed | ||
| SECONDARY | Loss of Less Than 5, 10, and 15 Letters in Visual Acuity in the Study Eye From Baseline, at Month 12 and 24 | Baseline to Month 12 and 24 | Early termination of the study, therefore the 12-month cutoff date was not reached and the related analysis was not performed | ||
| SECONDARY | Visual Acuity of 73 Letters or More in the Study Eye at Month 12 and 24 | Month 12 and 24 | Early termination of the study, therefore the 12-month cutoff date was not reached and the related analysis was not performed | ||
| SECONDARY | Average Visual Acuity Change From Month 3 to Month 4 Through Month 24 in the Study Eye | Month 3 to Month 24 | Early termination of the study, therefore the 12-month cutoff date was not reached and the related analysis was not performed | ||
| SECONDARY | Average Visual Acuity Change From Baseline to Month 1 Through Month 12 and 24 in the Study Eye | Baseline to Month 12 and 24 | Early termination of the study, therefore the 12-month cutoff date was not reached and the related analysis was not performed | ||
| SECONDARY | Change From Baseline in Central Sub-Field Thickness (CSFT) and Central Sub-Field Volume (CSFV) of the Study Eye Over Time | Baseline to Month 12 and 24 | Early termination of the study, therefore the 12-month cutoff date was not reached and the related analysis was not performed | ||
| SECONDARY | Dry Retina in the Study Eye on OCT at Month 12 and 24 | Month 12 and 24 | Early termination of the study, therefore the 12-month cutoff date was not reached and the related analysis was not performed | ||
| SECONDARY | Change From Baseline in Lesion Size and Morphology Based on Fluorescein Angiography at Month 12 and 24 | Baseline to Month 12 and 24 | Early termination of the study, therefore the 12-month cutoff date was not reached and the related analysis was not performed | ||
| SECONDARY | Treatment Patterns Over Time in Both Treatment Arms | Baseline to Month 12 and 24 | Early termination of the study, therefore the 12-month cutoff date was not reached and the related analysis was not performed | ||
| SECONDARY | Change From Baseline in the National Eye Institute Visual Functioning Questionnaire (NEI-VFQ-25) Scores Over Time | Baseline to Month 12 and 24 | Early termination of the study, therefore the 12-month cutoff date was not reached and the related analysis was not performed | ||
| SECONDARY | Frequency and Severity of Ocular and Non-ocular Adverse Events Over Time | Screening to Month 12 and 24 | Early termination of the study, therefore the 12-month cutoff date was not reached and the related analysis was not performed |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01780935/outcomes